Bazemore Robert B Insider Trading
Get the latest insider transactions of Bazemore Robert B. Bazemore Robert B is Chief Operating Officer in SYNAGEVA BIOPHARMA CORP ($GEVA) and Director in ARDELYX, INC. ($ARDX) and President & CEO in Epizyme, Inc. ($EPZM) and Director in Neon Therapeutics, Inc. ($NTGN) and Director in Nuvation Bio Inc. ($PANA). Discover the current value of Bazemore Robert B shares.
Address: 33 HAYDEN AVE LEXINGTON 02421MA
Bazemore Robert B is Insider in these Companies
Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
---|---|---|---|---|
GEVA | SYNAGEVA BIOPHARMA CORP | Chief Operating Officer | 0 | 0.00 |
EPZM | Epizyme, Inc. | President & CEO | 331,977 | 4,000,322.85 |
ARDX | ARDELYX, INC. | Director | 0 | 0.00 |
NTGN | Neon Therapeutics, Inc. | Director | 0 | |
NUVB | Nuvation Bio Inc. | Director | 5,000 |
Insider Trading Transactions of Bazemore Robert B
Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
---|---|---|---|---|---|---|---|---|---|
Apr 01 2021 | NUVB | Nuvation Bio Inc. | Bazemore Robert B | Director | Buy | 9.98 | 5,000 | 49,900 | 5,000 |
Feb 12 2021 | PANA | Nuvation Bio Inc. | Bazemore Robert B | Director | Option Exercise | 4.60 | 51,703 | 237,834 | 51,703 |
Feb 12 2021 | PANA | Nuvation Bio Inc. | Bazemore Robert B | Director | Option Exercise | 1.74 | 187,658 | 326,525 | 187,658 |
Feb 05 2021 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Sell | 11.21 | 3,890 | 43,607 | 331,977 |
Feb 02 2021 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Buy | 0.00 | 87,500 | 0 | 335,867 |
Feb 02 2021 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Option Exercise | 11.02 | 417,443 | 4,600,222 | 417,443 |
Jan 27 2021 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Sell | 11.41 | 6,069 | 69,247 | 248,367 |
Jun 30 2020 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Buy | 0.00 | 10,500 | 0 | 254,871 |
Jun 30 2020 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Sell | 16.15 | 4,773 | 77,084 | 250,098 |
Jun 22 2020 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Buy | 8.98 | 10,000 | 89,800 | 264,371 |
Jun 22 2020 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Sell | 22.00 | 10,000 | 220,000 | 254,371 |
Jun 22 2020 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Sell | 22.00 | 10,000 | 220,000 | 244,371 |
Jun 22 2020 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Option Exercise | 8.98 | 10,000 | 89,800 | 323,333 |
Jun 11 2020 | ARDX | ARDELYX, INC. | Bazemore Robert B | Director | Option Exercise | 7.31 | 23,500 | 171,785 | 23,500 |
May 06 2020 | NTGN | Neon Therapeutics, Inc. | Bazemore Robert B | Director | Option Exercise | 7.56 | 28,000 | 211,680 | 0 |
May 06 2020 | NTGN | Neon Therapeutics, Inc. | Bazemore Robert B | Director | Option Exercise | 4.64 | 18,500 | 85,840 | 0 |
Mar 26 2020 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Sell | 0.00 | 56,537 | 0 | 80,726 |
Mar 26 2020 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Buy | 0.00 | 113,393 | 0 | 250,656 |
Mar 26 2020 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Buy | 0.00 | 7,000 | 0 | 257,656 |
Mar 26 2020 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Sell | 15.28 | 3,285 | 50,195 | 254,371 |
Mar 26 2020 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Option Exercise | 8.98 | 79,167 | 710,920 | 333,333 |
Mar 26 2020 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Option Exercise | 12.45 | 2,371 | 29,519 | 333,333 |
Mar 26 2020 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Option Exercise | 9.12 | 48,727 | 444,390 | 298,737 |
Mar 26 2020 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Option Exercise | 16.14 | 73,409 | 1,184,821 | 73,409 |
Mar 26 2020 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Sell | 0.00 | 56,537 | 0 | 80,726 |
Mar 26 2020 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Buy | 0.00 | 113,393 | 0 | 250,656 |
Mar 26 2020 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Buy | 0.00 | 7,000 | 0 | 257,656 |
Mar 26 2020 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Sell | 15.28 | 3,285 | 50,195 | 254,371 |
Mar 26 2020 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Option Exercise | 8.98 | 79,167 | 710,920 | 333,333 |
Mar 26 2020 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Option Exercise | 12.45 | 2,371 | 29,519 | 333,333 |
Mar 26 2020 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Option Exercise | 9.12 | 48,727 | 444,390 | 298,737 |
Mar 26 2020 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Option Exercise | 16.14 | 73,409 | 1,184,821 | 73,409 |
Feb 05 2020 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Buy | 0.00 | 52,595 | 0 | 137,263 |
Feb 05 2020 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Option Exercise | 21.39 | 252,956 | 5,410,729 | 252,956 |
Jan 27 2020 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Buy | 0.00 | 8,750 | 0 | 93,744 |
Jan 27 2020 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Sell | 24.62 | 3,002 | 73,909 | 90,742 |
Jan 27 2020 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Sell | 20.44 | 6,074 | 124,153 | 84,668 |
Jun 27 2019 | NTGN | Neon Therapeutics, Inc. | Bazemore Robert B | Director | Option Exercise | 4.64 | 18,500 | 85,840 | 18,500 |
Jun 17 2019 | ARDX | ARDELYX, INC. | Bazemore Robert B | Director | Option Exercise | 2.74 | 50,000 | 137,000 | 50,000 |
Jun 14 2019 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Buy | 0.00 | 7,000 | 0 | 87,068 |
Jun 14 2019 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Sell | 12.10 | 2,074 | 25,095 | 84,994 |
Jan 28 2019 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Buy | 0.00 | 75,383 | 0 | 80,068 |
Jan 28 2019 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Option Exercise | 9.12 | 347,464 | 3,168,872 | 347,464 |
Jan 28 2019 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Buy | 0.00 | 75,383 | 0 | 80,068 |
Jan 28 2019 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Option Exercise | 9.12 | 347,464 | 3,168,872 | 347,464 |
Nov 07 2018 | NTGN | Neon Therapeutics, Inc. | Bazemore Robert B | Director | Option Exercise | 7.56 | 28,000 | 211,680 | 28,000 |
Nov 07 2018 | NTGN | Neon Therapeutics, Inc. | Bazemore Robert B | Director | Option Exercise | 7.56 | 28,000 | 211,680 | 28,000 |
Jun 15 2018 | ARDX | ARDELYX, INC. | Bazemore Robert B | Director | Option Exercise | 4.03 | 15,000 | 60,450 | 15,000 |
Feb 13 2018 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Option Exercise | 16.00 | 265,860 | 4,253,760 | 265,860 |
Jun 09 2017 | ARDX | ARDELYX, INC. | Bazemore Robert B | Director | Option Exercise | 4.30 | 15,000 | 64,500 | 15,000 |
Feb 09 2017 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Option Exercise | 12.45 | 335,704 | 4,179,515 | 335,704 |
Sep 01 2016 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Buy | 6.21 | 1,362 | 8,463 | 1,362 |
Jun 06 2016 | ARDX | ARDELYX, INC. | Bazemore Robert B | Director | Option Exercise | 9.27 | 25,000 | 231,750 | 25,000 |
Feb 10 2016 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Option Exercise | 8.98 | 412,500 | 3,704,250 | 412,500 |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA CORP | Bazemore Robert B | Chief Operating Offic ... | Sell | 0.00 | 35,000 | 0 | 0 |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA CORP | Bazemore Robert B | Chief Operating Offic ... | Option Exercise | 63.11 | 50,000 | 3,155,500 | 0 |
Jun 09 2015 | GEVA | SYNAGEVA BIOPHARMA CORP | Bazemore Robert B | Chief Operating Offic ... | Buy | 0.00 | 5,000 | 0 | 35,000 |
Sep 25 2014 | GEVA | SYNAGEVA BIOPHARMA CORP | Bazemore Robert B | Chief Operating Offic ... | Buy | 0.00 | 30,000 | 0 | 30,000 |
Sep 25 2014 | GEVA | SYNAGEVA BIOPHARMA CORP | Bazemore Robert B | Chief Operating Offic ... | Option Exercise | 63.11 | 50,000 | 3,155,500 | 50,000 |